p27Kip1 immunostaining for the differential diagnosis of small B-cell neoplasms in trephine bone marrow biopsies

Modern Pathology

Volumn 14, Issue 10, 2001, Pages 1022-1029

  Kremer, Marcus ^a,b   Dirnhofer, Stephan ^c,d   Nickl, Anna ^b   Hoefler, Heinz ^a,b   Quintanilla Martínez, Leticia ^b   Fend, Falko ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Bone marrow infiltrates; Differential diagnosis; Hairy cell leukemia; Immunohistochemistry; Mantle cell lymphoma; p27kip1 protein; Small B cell non Hodgkin lymphoma

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CHROMOSOME TRANSLOCATION 11; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENE REARRANGEMENT; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

ANTIGENS, CD3; BIOPSY; BONE MARROW; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, SMALL-CELL; TUMOR SUPPRESSOR PROTEINS;

EID: 0034775432     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880429     Document Type: Article

References (42)

1. Reticulin fiber content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy): A morphometric evaluation before and after therapy
2. Bone marrow trephine biopsy in lymphoproliferative disease
3. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas
4. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma
5. Tumors of the bone marrow
6. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow
7. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
8. Mantle-cell lymphoma
9. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic and molecular data
10. Mantle cell lymphoma: A clinicopathologic study of 80 cases
11. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study
12. Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period
13. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma
14. Cyclin D1 expression in non-Hodgkin's lymphomas
15. Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: Is there a reliable method?
16. Optimizing cyclin D1 immunostaining of mantle cell lymphoma
17. Role of the cyclin-dependent kinase inhibitors in the development of cancer
18. CDK inhibitors: Positive and negative regulators of G1-phase progression
19. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
20. Increased proteasome-dependent degradation of the cyclin dependent kinase inhibitor p27 in aggressive colorectal carcinomas
21. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas
22. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
23. Cyclin-dependent kinase inhibitor p27kip1 in lymphoid tissue: p27 kip1 expression is inversely proportional to the proliferative index
24. Mantle cell lymphomas lack expression of p27/kip1, a cyclin-dependent kinase inhibitor
25. Increased proteasome degradation of cyclindependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma
26. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report
27. Blastoid variants of mantle cell lymphoma: Frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones
28. Monoclonal antibody B-ly7: A sensitive marker for detection of minimal residual disease in hairy cell leukemia
29. The value of the monoclonal antibody, DBA.44, in the diagnosis of B-lymphoid disorders
30. Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44
31. Molecular methods for detecting t(11;14) translocations in mantle-cell lymphomas
32. Expression of p21/cip1/waf1/sdi1 and p27/kip1 cyclin-dependent kinase inhibitors during human hematopoiesis
33. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma
34. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma. Analysis with multiple breakpoint probes
35. Mantle cell lymphoma: Rapid polymerase chain reaction-based genotyping of a morphologically heterogeneous entity
36. Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin embedded tissues
37. Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue
38. Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia
39. Involvement of the CCND1 gene in hairy cell leukemia
40. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia
41. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukemia
42. Transcriptional and post-transcriptional mechanisms induce cyclin D1 over-expression in chronic lymphoproliferative disorders